Skip to content
Investment Visual
/
Backtest
Tools
Browse
Stocks
ISRG
Financials
Revenue by product
ISRG
Intuitive Surgical, Inc.
Backtest
ISRG
Overview
Returns
Financials
Holders
Insiders
Summary
Statements
Income
Revenue
Revenue by product
Gross profit
Operating income
Net income
EPS
EBITDA
Cash flow
Balance sheet
Valuation
Shares and dividends
Costs
Revenue by product
Annual
Quarterly
Revenue by product
Annual
Quarterly
2025, ended Dec 31, 2025
Instruments and accessories
$6.0B
60%
Systems
$2.5B
25%
Service
$1.6B
16%
Products by fiscal year
CSV
Products by fiscal year
USD
Line, in USD
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Product
8.49B
7.05B
5.96B
5.20B
4.79B
3.63B
3.75B
3.09B
2.57B
2.20B
Instruments and accessories
6.02B
5.08B
4.28B
3.52B
3.10B
2.46B
2.41B
1.96B
1.64B
1.40B
Systems
2.47B
1.97B
1.68B
1.68B
1.69B
1.18B
1.35B
1.13B
0.93B
0.80B
Service
1.57B
1.31B
1.17B
1.02B
0.92B
0.72B
0.72B
0.64B
0.57B
0.51B
Total
10.1B
8.4B
7.1B
6.2B
5.7B
4.4B
4.5B
3.7B
3.1B
2.7B
More Intuitive Surgical financials
Revenue
Gross profit
Operating income
Net income
EPS
EBITDA
Revenue at other companies
ABBV
AbbVie Inc.
MRK
Merck & Co., Inc.
AMGN
Amgen Inc.
GILD
Gilead Sciences, Inc.
ABT
Abbott Laboratories
PFE
Pfizer Inc.
Tools
Return calculator